Takeda posts results of Phase 3 TAK-279 study in psoriasis
The study enrolled 18 participants and completed primary data collection on October 17, 2025. Results were first posted on ClinicalTrials.gov on November 4, 2026.
Primary source
ClinicalTrials.gov results record, November 4, 2026
A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
Read the source: A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation